A Novel Antitumor Antibiotic, KW‐2189 Is Activated by Carboxyl Esterase and Induces DNA Strand Breaks in Human Small Cell Lung Cancer Cells

KW‐2189 has been selected as a lead compound for clinical trial among duocarmycin derivatives with structural similarity to CC‐1065, a cyclopropylpyrroloindole. The purpose of this study was to examine the DNA‐binding potency and the mechanisms of cytotoxicity of KW‐2189. In order to analyze DNA‐bin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogasawara, Hayato, Nishio, Kazuto, Takeda, Yuichiro, Ohmori, Tohru, Kubota, Naohiro, Funayama, Yasunori, Ohira, Tatsuo, Kuraishi, Yasunobu, Isogai, Yukihide, Saijo, Nagahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1994
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919473/
https://www.ncbi.nlm.nih.gov/pubmed/8200853
http://dx.doi.org/10.1111/j.1349-7006.1994.tb02375.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919473/
https://www.ncbi.nlm.nih.gov/pubmed/8200853
http://dx.doi.org/10.1111/j.1349-7006.1994.tb02375.x

Ejemplares similares